We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$90.1B
AUM Growth
+$13.3B
Cap. Flow
+$9.06B
Cap. Flow %
10.06%
Top 10 Hldgs %
36.25%
Holding
7,163
New
665
Increased
2,829
Reduced
2,730
Closed
446

Sector Composition

Rank Sector Weight
1 Technology 4.55%
2 Healthcare 3.86%
3 Financials 3.37%
4 Consumer Discretionary 2.98%
5 Communication Services 2.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XENT
4726
DELISTED
Intersect ENT, Inc
XENT
$65K ﹤0.01%
4,049
+2,526
+166% +$38K
MDP
4727
DELISTED
Meredith Corporation
MDP
$65K ﹤0.01%
1,238
+516
+71% +$27.5K
CBPX
4728
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
$65K ﹤0.01%
3,076
-7,112
-70% -$160K
UCFC
4729
DELISTED
United Community Financial Corp
UCFC
$65K ﹤0.01%
9,248
+141
+2% +$940
AVNT icon
4730
Avient
AVNT
$3.43B
$64K ﹤0.01%
1,892
-919
-33% -$31.8K
CCOI icon
4731
Cogent Communications
CCOI
$663M
$64K ﹤0.01%
1,748
-432
-20% -$16.7K
FBT icon
4732
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.71B
$64K ﹤0.01%
645
IRM icon
4733
CALL
Iron Mountain
IRM
$36.9B
$64K ﹤0.01%
1,700
-3,500
-67% -$135K
LXRX icon
4734
Lexicon Pharmaceuticals
LXRX
$1.03B
$64K ﹤0.01%
3,591
-59,625
-94% -$960K
LXU icon
4735
LSB Industries
LXU
$707M
$64K ﹤0.01%
9,597
+7,257
+310% +$61.7K
VIAV icon
4736
CALL
Viavi Solutions
VIAV
$9.31B
$64K ﹤0.01%
8,600
+1,400
+19% +$10.3K
GBT
4737
DELISTED
Global Blood Therapeutics, Inc.
GBT
$64K ﹤0.01%
2,791
+381
+16% +$7.26K
GLUU
4738
PUT
DELISTED
Glu Mobile Inc.
GLUU
$64K ﹤0.01%
28,700
LOGM
4739
DELISTED
LogMein, Inc.
LOGM
$64K ﹤0.01%
695
+551
+383% +$44.1K
PGNX
4740
CALL
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$64K ﹤0.01%
10,100
+9,300
+1,163% +$56.2K
AYR
4741
CALL
DELISTED
Aircastle Ltd
AYR
$64K ﹤0.01%
3,200
+300
+10% +$6.29K
FCAM
4742
DELISTED
Fiat Chrysler Automobiles N.V.
FCAM
-134,464
Closed -$8.61M
GI
4743
DELISTED
EndoChoice Holdings, Inc.
GI
$64K ﹤0.01%
7,935
+638
+9% +$2.99K
DBI icon
4744
CALL
Designer Brands
DBI
$331M
$63K ﹤0.01%
3,100
-37,200
-92% -$872K
IWF icon
4745
CALL
iShares Russell 1000 Growth ETF
IWF
$124B
$63K ﹤0.01%
2,400
-13,600
-85% -$354K
ZNGA
4746
PUT
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$63K ﹤0.01%
21,800
-3,800
-15% -$10.6K
CSLT
4747
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$63K ﹤0.01%
15,316
+15,230
+17,709% +$62.2K
UNT
4748
DELISTED
UNIT Corporation
UNT
$63K ﹤0.01%
3,405
+2,286
+204% +$35.2K
CRC
4749
PUT
DELISTED
California Resources Corporation
CRC
$63K ﹤0.01%
5,040
+3,070
+156% +$35K
UFS
4750
PUT
DELISTED
DOMTAR CORPORATION (New)
UFS
$63K ﹤0.01%
1,700
+1,200
+240% +$44.2K

Similar funds

Barclays's Q3 2016 Portfolio in Review

As of Q3 2016, Barclays held 7,163 positions worth $90.1B, up 17% from $76.9B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Barclays deployed $9.06B of net new capital in Q3 2016, opening 665 new positions and adding to 2,829 existing holdings. Its largest new stake was Dell: 9,434,097 shares worth $127M.

By sector, the portfolio is most concentrated in Technology at 4.5% of assets, down from 5.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $593M trimmed.

  • Barclays's largest Q3 2016 buy was Dell: 9,434,097 shares worth $127M.
  • Barclays added most to Procter & Gamble in Q3 2016, an estimated $490M increase.
  • Barclays's biggest Q3 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $593M.
  • Barclays fully exited EMC CORPORATION in Q3 2016, selling an estimated $225M.
  • Barclays's ten largest holdings make up 36% of its $90.1B portfolio in Q3 2016.
  • Barclays opened 665 new positions and closed 446 in Q3 2016.
  • Barclays's portfolio value rose 17% quarter-over-quarter to $90.1B.

Based on Barclays's 13F filing for Q3 2016, filed 14 Nov 2016.